Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ALLOGENE THERAPEUTICS, INC.

(ALLO)
  Rapport
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
 OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws over ALLOGENE THERAPEUTICS, INC.
25/01Allogene Therapeutics zegt dat preklinische resultaten DLL3 ondersteunen als potentiële..
MT
25/01Allogene Therapeutics publiceert preklinische gegevens in klinisch kankeronderzoek ter ..
CI
24/01Allogene Therapeutics kondigt de publicatie in Nature Medicine aan van gegevens van zij..
CI
24/01Allogene Therapeutics, Inc. : JPMorgan Chase is positief ove..
MM
11/01Transcript : Allogene Therapeutics, Inc. Presents at 41st Annual J.P. Morgan ..
CI
06/01Allogene Therapeutics, Inc. : Baird past advies aan
MM
05/01Allogene Therapeutics, Inc. : EF Hutton herhaalt koopadvies
MM
03/01Allogene Therapeutics, Inc. Kondigt het ontslag aan van Rafael G. Amado als Uitvoerend ..
CI
03/01Allogene benoemt Zachary J. Roberts tot Executive Vice President Research & Development
CI
2022Allogene Therapeutics, Inc. : BofA Securities verlaagt advie..
MM
2022Allogene Therapeutics R&D Showcase bevat vorderingen op het gebied van hematologische e..
CI
2022Transcript : Allogene Therapeutics, Inc. - Special Call
CI
2022Allogene Therapeutics, Inc. : HC Wainwright bevestigt koopa..
MM
2022Transcript : Allogene Therapeutics, Inc., Q3 2022 Earnings Call, Nov 02, 2022
CI
2022Allogene Therapeutics, Inc. Rapporteert winstresultaten voor het derde kwartaal en de n..
CI
2022Allogene Overland Biopharm voltooit bouw van cGMP-productiefaciliteit in Shanghai ter o..
CI
2022Allogene Therapeutics Inc. lanceert CAR T Together, gericht op versnelde ontwikkeling e..
CI
Al het nieuws
Nieuws in andere talen op ALLOGENE THERAPEUTICS, INC.
25/01Allogene Therapeutics Says Preclinical Results Back DLL3 as Potential Treatment for Lun..
25/01Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1..
25/01Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting..
25/01Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting..
25/01Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting..
25/01North American Morning Briefing: Microsoft -2-
24/01Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1..
24/01Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1..
17/01Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
09/01North American Morning Briefing: 'Soft Landing' -3-
Meer nieuws
Analistenadviezen over ALLOGENE THERAPEUTICS, INC.
24/01Allogene Therapeutics, Inc. : JPMorgan Chase is positief ove..
MM
06/01Allogene Therapeutics, Inc. : Baird past advies aan
MM
05/01Allogene Therapeutics, Inc. : EF Hutton herhaalt koopadvies
MM
2022Allogene Therapeutics, Inc. : BofA Securities verlaagt advie..
MM
2022Allogene Therapeutics, Inc. : HC Wainwright bevestigt koopa..
MM
Meer adviezen
Bedrijfsnieuws
25/01Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1..
AQ
25/01Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting..
GL
25/01Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting..
GL
24/01Allogene Therapeutics Announces Publication in Nature Medicine of Data from its Phase 1..
GL
17/01Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
GL
Meer persberichten
Volgende evenement op ALLOGENE THERAPEUTICS, INC.